In an interaction with India Pharma Outlook, Nandakumar Kalathil, AVP Sales India at Agilent Technologies, discusses how high-resolution mass spectrometry is revolutionizing early disease detection in India by enhancing cancer biomarker sensitivity,
Cipla has launched ZEMDRI (Plazomicin) in India as a brand-new intravenous antibiotic for use against complicated urinary tract infections (cUTI) such as pyelonephritis. Since 150 million people globally and rising antimicrobial resistance are huge c
In its ongoing commitment to raising awareness of critical pediatric health concerns, Ameera Shah-led Metropolis Healthcare Limited.
Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced its financial results for the fourth quarter and year ended on March 31st, 2025...
NABL Launches Dedicated Software for Lab QR & ULR AdoptionAnticipating the implementation issues of some Conformity Assessment Bodies (CABs), the National Accreditation Board for Testing and Calibration Laboratories (NABL) has proposed a pragmatic..
Helsinki Hospital Uses BNCT to Treat First Cancer PatientsNeutron Therapeutics LLC and Helsinki University Hospital have unveiled a groundbreaking milestone in treating cancer: the first patients in Europe have undergone accelerator-based boron...
BioMarin to Acquire Inozyme Pharma for USD 270 MillionBioMarin Pharmaceutical, Inc. has publicly disclosed a definitive agreement to acquire Inozyme Pharma, Inc in an all-cash transaction of nearly USD 270 million...
74th Indian Pharmaceutical Congress 2025 Opens RegistrationsThe Indian Pharmaceutical Congress, 2025 (IPC), which is organized by the Association of Pharmaceutical Teachers of India (APTI), has opened its registration...
Scientists at the National Institutes of Health (NIH) have found that alterations in the structure and cell composition of breast connective tissue, or stroma, are associated with a heightened risk for aggressive breast cancer in women with benign...
In an interaction with India Pharma Outlook, C. Mukundan, Managing Director, Atozeta Health Solutions, shared his valuable inputs on how AI-driven personalization and omnichannel scientific engagement are redefining pharma brand-building...
, CDSCO.jpg)